VRP-Corner

How to Determine the Price of a Pharmaceutical: the Case of Hepatitis-C-Virus

19.11.2015

Journées Pluridisciplinaires Hépatobiliaires, Pancréatiques et Digestives, Geneva

The health economic concept of cost-effectiveness ensures that the price of a pharmaceutical reflects its value. Can this price be applied within a high prevalence indication and help lead a majority of health systems the way to bankruptcy? When aiming to control drug expenditure, pharmaceutical pricing isn't the only issue to be raised. Publically funded innovation and pay-for-performance are concepts that offer stakeholders coping strategies for rising pharmaceutical spending and help ensure an available and accessible health care system.

Zur Präsentation (PDF, 3MB) (auf Englisch)